Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tope Tunji Odunitan"'
Autor:
Abdul-Quddus Kehinde Oyedele, Nurudeen Abiodun Owolabi, Tope Tunji Odunitan, Abosede Ajibare Christiana, Rukayat Olajumoke Jimoh, Waliu Olatunji Abdul Azeez, Maryam Bello-Hassan Titilayo, Abiola Sarah Soares, Adedayo Toluwani Adekola, Teslim Oluwaseyi Abdulkareem, Samson Olabode Oyelekan, Mojeed Ayoola Ashiru, Ibrahim Olajide Gbadebo, Habeebah Eyinade Olajumoke, Ibrahim Damilare Boyenle, Abdeen Tunde Ogunlana
Publikováno v:
Informatics in Medicine Unlocked, Vol 37, Iss , Pp 101170- (2023)
A prospective target for the therapy of solid tumors is KRAS G12D, the most prevalent oncogenic KRAS mutation. However, despite decades of research that focused on the identification of druggable compounds against this highly challenging therapeutic
Externí odkaz:
https://doaj.org/article/5d49b7965d9e448483893b2f7c5a0d6b
Autor:
Abdul-Quddus Kehinde, Oyedele, Abdeen Tunde, Ogunlana, Ibrahim Damilare, Boyenle, Ayodeji Oluwadamilare, Adeyemi, Temionu Oluwakemi, Rita, Temitope Isaac, Adelusi, Misbaudeen, Abdul-Hammed, Oluwabamise Emmanuel, Elegbeleye, Tope Tunji, Odunitan
Publikováno v:
Molecular Diversity.
The continuous approval of covalent drugs in recent years for the treatment of diseases has led to an increased search for covalent agents by medicinal chemists and computational scientists worldwide. In the computational parlance, molecular docking
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e91494aace2467605e9e010edc6de7f
https://doi.org/10.1007/s11030-022-10523-4
https://doi.org/10.1007/s11030-022-10523-4